Azithromycin for Shigella Infection
Azithromycin is a highly effective first-line treatment for shigellosis, with a recommended regimen of 500 mg on day 1 followed by 250 mg daily for days 2-5 in adults, or 10 mg/kg (max 500 mg) on day 1 followed by 5 mg/kg daily (max 250 mg) on days 2-5 in children. 1, 2
Rationale for Azithromycin as First-Line
The most recent WHO guidelines (2024) explicitly recommend azithromycin as an alternative oral choice for shigellosis, particularly in regions with high fluoroquinolone resistance 1. This represents a significant shift from older recommendations that prioritized ciprofloxacin, driven by:
- Rising fluoroquinolone resistance: Resistance rates to nalidixic acid and ciprofloxacin have progressively increased, particularly in Asia-Africa where rates reached 33.6% and 5.0% respectively 1
- Proven efficacy: Azithromycin demonstrates 82-94% clinical success rates and 94-100% bacteriologic eradication in shigellosis 3, 4, 5
- Strong guideline support: The 2017 travelers' diarrhea guidelines give azithromycin a "strong recommendation, high level of evidence" for dysentery treatment 2
Specific Dosing Regimens
Adults
- Standard 5-day course: 500 mg on day 1, then 250 mg daily on days 2-5 1, 2
- Alternative single-dose: 1 gram as a single dose (though 5-day course preferred for shigellosis) 2
Children
- 5-day course: 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg daily (maximum 250 mg) on days 2-5 1, 6
- Alternative 3-day course: 10 mg/kg daily for 3 days 4, 5
Infants <6 months
- 10 mg/kg per day for 5 days 6
When to Use Azithromycin vs. Ciprofloxacin
Choose azithromycin preferentially when:
- Treating dysentery (bloody diarrhea with fever, abdominal cramps, tenesmus) 2
- Patient has traveled to areas with known fluoroquinolone resistance (Southeast Asia, India, sub-Saharan Africa) 2
- Treating children (avoids arthropathy concerns with fluoroquinolones) 1
- Local resistance patterns show >10% ciprofloxacin resistance 1
Ciprofloxacin (15 mg/kg or 500 mg twice daily for 3 days) remains acceptable when:
- Local susceptibility patterns confirm low fluoroquinolone resistance 1
- Azithromycin is unavailable 1
- However, note that ciprofloxacin is no longer first-line due to widespread resistance 2
Alternative Second-Line Options
If azithromycin fails or is contraindicated:
- Cefixime: Effective oral cephalosporin option 1
- Ceftriaxone: Parenteral option for severe cases (resistance rates 2.5% in Asia-Africa) 1, 4, 5
Critical Caveats
Emerging azithromycin resistance: Recent outbreak data shows treatment failures with azithromycin when isolates contain mph(A) and erm(B) resistance genes with MICs >16 µg/mL 7. In one Vermont outbreak, all 4 patients treated with azithromycin experienced clinical failure 7. This underscores the importance of:
- Obtaining stool cultures when possible
- Monitoring clinical response at 48-72 hours
- Switching antibiotics if no improvement occurs 8
Do not use for asymptomatic carriers: Mass prophylaxis is not recommended 8. Treat only symptomatic patients with confirmed or highly suspected shigellosis.
Avoid older agents: Ampicillin and trimethoprim-sulfamethoxazole show 37% combined resistance rates in the US and should not be used empirically 9, 10.